EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Prostate Cancer and Prostatic Diseases

ISSN 1365-7852 · Springer Science and Business Media LLC

Latest articles

  1. Phase I trial of using a prostatic urethral lift implant with stereotactic ablative body radiotherapy for men with prostate cancer and benign prostatic hyperplasia (NCT05311527)

    Young Suk Kwon, Reena Kudchadker, Neil B. Desai, Raquibul Hannan, MinJae Lee, Ryan Mauck, Jennifer Tse, Kris Gaston, Tamara Dickinson, Shaghayegh Rezaie, Brad Hornberger, Daniel Yang, Maricruz Ibarra, Howard Morgan, Yang Kyun Park, Yesenia Gonzalez, Claus Roehrborn, Robert Timmerman, Solomon Woldu, Aurelie Garant

    Published: 2026-11-16DOI: 10.1038/s41391-026-01169-6

  2. Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial

    Melis Guer, Alon Lazarovich, Ferdinand Luger, Hannes Cash, Sangeet Ghai, L. Felipe Urdaneta-Salegui, Christian P. Pavlovich, Joseph Brito, Neal D. Shore, Julian P. Struck, Martin Schostak, Niklas Harland, Moisés Rodriguez-Socarrás, Wayne G. Brisbane, Giovanni Lughezzani, Harry Toledano, Mohammed Salah Ouertani, Petr Macek, Christopher Fung, Wendy Tu, Andreas Gusenleitner, Karsten Günzel, Peter F. Incze, Arvin K. George, José G. Pereira, Robert Jansen, Joseph Renzulli, Laurence Klotz, Adam Kinnaird

    Published: 2026-10-28DOI: 10.1038/s41391-026-01171-y

  3. Risk factors for incidental prostate cancer following surgery for benign prostatic enlargement: A systematic review and meta-analysis

    Angelo Cormio, Akihiro Matsukawa, Alessandro Dematteis, Ahmed R. Alfarhan, Marcin Miszczyk, Navid Roessler, Abdulrahman S. Alqahtani, Stefano Mancon, Ichiro Tsuboi, Paweł Rajwa, Ugo Giovanni Falagario, Francesca Sanguedolce, Gian Maria Busetto, Carlo Bettocchi, Giuseppe Carrieri, Luigi Cormio, Andrea Benedetto Galosi, David D’Andrea, Takahiro Kimura, Shahrokh F. Shariat

    Published: 2026-10DOI: 10.1038/s41391-026-01108-5

  4. Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

    Udit Singhal, Ralph Jiang, James A. Proudfoot, Elizabeth Chase, Krithika Suresh, Elai Davicioni, Tudor Borza, Michael J. Zelefsky, Brian J. Davis, Brad J. Stish, R. Jeffrey Karnes, Stephen J. Freedland, Martha K. Terris, William J. Aronson, Matthew R. Cooperberg, Fabio Y. Moraes, Alejandro Berlin, Curtiland Deville, Nicholas G. Zaorsky, Soumyajit Roy, Angela Y. Jia, Jonathan E. Shoag, William C. Jackson, Daniel E. Spratt, Matthew Schipper, Todd M. Morgan, Robert T. Dess

    Published: 2026-09DOI: 10.1038/s41391-025-01062-8

  5. Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study

    Thomas Büttner, Mimma Rizzo, Laura Bernal Vaca, Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Alvaro Juárez, Tomas Buchler, Emmanuel Seront, Jakub Kucharz, María Natalia Gandur Quiroga, Maria T. Bourlon, Martin Bögemann, Jindrich Kopecky, Pasquale Rescigno, Ondrej Fiala, Alejo Rodriguez-Vida, Zin W. Myint, Yüksel Ürün, Sarah Scagliarini, Alexandr Poprach, Diana Matthews, Haoran Li, Alessandro Rizzo, Alessandra Mosca, Edoardo Lenci, Bohuslav Melichar, Mike Wenzel, Philipp Mandell, Francesco Massari, Emmanuel S. Antonarakis, Matteo Santoni

    Published: 2026-09DOI: 10.1038/s41391-025-01067-3

  6. Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients

    Neal D. Shore, Christopher M. Pieczonka, Sean Heron, Mukaram Gazi, David J. Cahn, Laurence H. Belkoff, Aaron D. Berger, Brian Mazzarella, Joseph Veys, David Morris, Richard Bevan-Thomas, Alexander Engelman, Paul Dato, David R. Wise, Mary Kay Hardwick, Kerry W. Aradhya, Brandie Heald, Robert L. Nussbaum, Kathryn E. Hatchell, Brianna Bucknor, Edward D. Esplin, Sarah M. Nielsen

    Published: 2026-06DOI: 10.1038/s41391-025-01013-3

Volumes

2026 · 1492025 · 2182024 · 1372023 · 1372022 · 1342021 · 1492020 · 912019 · 812018 · 722017 · 692016 · 672015 · 582014 · 582013 · 662012 · 632011 · 582010 · 672009 · 672008 · 732007 · 742006 · 742005 · 692004 · 732003 · 712002 · 852001 · 492000 · 1011999 · 1321998 · 461997 · 20

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.